Literature DB >> 24657006

Does group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment clients?

Susan M Paddock1, Sarah B Hunter2, Thomas J Leininger3.   

Abstract

Little is known about the effect of group therapy treatment modules on symptom change during treatment and on outcomes post-treatment. Secondary analyses of depressive symptoms collected from two group therapy studies conducted in substance use treatment settings were examined (n=132 and n=44). Change in PHQ-9 scores was modeled using longitudinal growth modeling combined with random effects modeling of session effects, with time-in-treatment interacted with module theme to test moderation. In both studies, depressive symptoms significantly decreased during the active treatment phase. Symptom reductions were not significantly moderated by module theme in the larger study. However, the smaller pilot study's results suggest that future examination of module effects is warranted, given the data are compatible with differential reductions in reported symptoms being associated with attending people-themed module sessions versus thoughts-themed sessions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Co-occurring disorders; Cognitive–behavioral therapy; Depression; Group therapy

Mesh:

Year:  2014        PMID: 24657006      PMCID: PMC4011957          DOI: 10.1016/j.jsat.2014.02.005

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  31 in total

1.  Professional and paraprofessional group treatments for depression: a comparison of cognitive-behavioral and mutual support interventions.

Authors:  J I Bright; K D Baker; R A Neimeyer
Journal:  J Consult Clin Psychol       Date:  1999-08

2.  The use of VA and non-VA mental health services by female veterans.

Authors:  R A Hoff; R A Rosenheck
Journal:  Med Care       Date:  1998-11       Impact factor: 2.983

3.  The drug abuse screening test.

Authors:  H A Skinner
Journal:  Addict Behav       Date:  1982       Impact factor: 3.913

4.  Detecting bipolar disorder among treatment-seeking substance abusers.

Authors:  K L Sloan; D Kivlahan; A J Saxon
Journal:  Am J Drug Alcohol Abuse       Date:  2000-02       Impact factor: 3.829

5.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

6.  A Bayesian model for the common effects of multiple predictors on mixed outcomes.

Authors:  Robert E Weiss; Juan Jia; Marc A Suchard
Journal:  Interface Focus       Date:  2011-08-31       Impact factor: 3.906

7.  Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness.

Authors:  S A Maisto; M P Carey; K B Carey; C M Gordon; J R Gleason
Journal:  Psychol Assess       Date:  2000-06

8.  Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care.

Authors:  B Dickey; H Azeni
Journal:  Am J Public Health       Date:  1996-07       Impact factor: 9.308

9.  Does initial treatment focus influence outcomes for depressed substance abusers?

Authors:  Michelle L Drapkin; Susan R Tate; John R McQuaid; Sandra A Brown
Journal:  J Subst Abuse Treat       Date:  2008-03-04

10.  Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study.

Authors: 
Journal:  Alcohol Clin Exp Res       Date:  2003-07       Impact factor: 3.455

View more
  1 in total

1.  Bayesian restricted spatial regression for examining session features and patient outcomes in open-enrollment group therapy studies.

Authors:  Susan M Paddock; Thomas J Leininger; Sarah B Hunter
Journal:  Stat Med       Date:  2015-08-13       Impact factor: 2.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.